Regencell Bioscience Holdings Limited (RGC)
Nasdaq: RGC · Medicinal Chemicals & Botanical Products · Hong Kong · filing with the SEC since 2020
Who runs Regencell Bioscience Holdings Limited
Officers and directors as they report to the SEC on Forms 3, 4 and 5, named as filedChief executive, as filed
Au Yat-Gai
Chief Executive Officer. First filing Mar 2026, latest Mar 18, 2026, 0 filings in all.
Officers reporting now
4
of 7 people with a filing in the last fifteen months
Directors reporting now
3
7 people on the record since 2026
Officerssales are open-market, Sep 30, 2025 to Sep 30, 2026
| Name | Title as filed | First filing | Latest filing | Sales, 12 months |
|---|---|---|---|---|
| Au Yat-Gai | Chief Executive Officer | Mar 2026 | Mar 18, 2026 | none |
| Chung James Wai Hong | COO and Chief Strategy Officer | Mar 2026 | Mar 18, 2026 | none |
| Au Yat-Pui | Chief Business Officer | Mar 2026 | Mar 18, 2026 | none |
| Chan Ho Yau | Financial Controller | Mar 2026 | Mar 18, 2026 | none |
Directorssales are open-market, Sep 30, 2025 to Sep 30, 2026
| Name | Role | First filing | Latest filing | Sales, 12 months |
|---|---|---|---|---|
| Hui Evana Yee Wah | director | Mar 2026 | May 29, 2026 | none |
| Lo William Wing Yan Dr | director | Mar 2026 | May 29, 2026 | none |
| Lo Margaret Hoor Han | director | Mar 2026 | Mar 18, 2026 | none |
A person is listed as reporting now after a filing in the last fifteen months. The record shows when someone last filed; it does not say why they stopped. Each name links to the filings on sec.gov.